Press Releases
Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.
Chairman of the Board of Medifast Inc.
Dr. DiBartolomeo will be developing this virtual clinic model with at least 50 Associate Medical Practitioners directing certified and trained Health Advisors. Opportunities to join this new network of health advisors will appear in the National News Media in the next few weeks. Interested parties should call 1-800-572-4417.
The Company has notified Health Inventions, Inc. of its intention to terminate its relationship on August 30, 2002, as it could not meet the Company's risk and credit standards.
Dr. DiBartolomeo, Vice President of Clinical Affairs for Medifast, formerly a 20-year veteran of Nutri-Systems, announces "The establishment of the new MEDSLIM™ Clinical Network." Physicians with a significant amount of patients desiring to focus on disease and weight management services now can join the "MEDSLIM Clinical Network" with a complete weight loss and disease management program to include a comprehensive marketing and advertising support program. MEDSLIM has already signed up 2 clinics in the first week and expects to have over 100 clinics in operation over the next 12 months, operated by qualified medical practitioners who desire to manage high volume clinics.
Medifast has signed a distribution and licensing agreement to provide diabetic and weight management products to Diabetes Direct, Inc. They became the first customer to distribute Medifast's new Diabetic Bars that are great tasting, contain only 1 gram of sugar, and are low glycemic ... ideal for diabetics. Medifast Plus for Diabetics, which is being clinically tested at Johns Hopkins University, is fast becoming a "star" in the Medifast product line.
This release contains forward-looking statements, which may involve known and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date.
SOURCE: Medifast, Inc.
CONTACT: Bradley T. MacDonald, Chairman & Chief Executive Officer of
Medifast, +1-410- 581-8042, ext. 231
Web site: http://www.medifast.net/